What are luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), and what are their normal serum levels in a healthy 22‑year‑old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What are LH and FSH and Their Normal Levels in a 22-Year-Old Female

Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are pituitary gonadotropins that regulate ovarian function, and in a healthy 22-year-old woman with regular menstrual cycles, normal levels vary throughout the cycle but typically range from approximately 2-9 IU/L for LH and 3-10 IU/L for FSH during the early follicular phase (menstrual cycle days 1-4).

What These Hormones Are

LH and FSH are glycoprotein hormones secreted by the anterior pituitary gland that orchestrate reproductive function 1:

  • FSH (Follicle-Stimulating Hormone): Stimulates follicular growth and maturation in the ovaries, promoting estradiol production
  • LH (Luteinizing Hormone): Triggers ovulation at mid-cycle and stimulates progesterone production by the corpus luteum

These hormones work in concert to regulate the menstrual cycle, with FSH predominating in the follicular phase and LH surging at ovulation 1.

Normal Reference Ranges for a 22-Year-Old Woman

The interpretation of LH and FSH is highly dependent on menstrual cycle phase, making timing of measurement critical 2:

Early Follicular Phase (Days 1-4)

Based on research in young reproductive-age women (20-25 years), normal ranges are 3:

  • FSH: Approximately 3-10 IU/L
  • LH: Approximately 2-9 IU/L
  • LH/FSH ratio: Typically <1 in this age group

Mid-Cycle LH Surge (Day 0)

  • LH: Can rise dramatically to 20-80 IU/L
  • FSH: Also increases but less dramatically than LH
  • High FSH and LH with estradiol >150 pg/mL indicates the midcycle gonadotropin surge 4

Luteal Phase

  • LH: Remains moderately elevated compared to early follicular phase
  • FSH: Lower than follicular phase 5

Critical Clinical Context

Pattern Matters More Than Absolute Values

The Endocrine Society emphasizes that the pattern of hormone levels is more critical than absolute values 4. Key patterns include:

  • Normal cycling women: FSH is usually higher than LH in the early follicular phase, with both showing cyclic variation 5
  • Ovarian insufficiency: Elevated FSH and LH (often >20-40 IU/L) with low estradiol (<20 pg/mL) 4
  • Functional hypothalamic amenorrhea: Low or low-normal LH with normal FSH (FSH usually higher than LH) 4

Age-Related Considerations

At 22 years old, this woman is in her peak reproductive years. Research shows that FSH levels begin rising as early as age 29-30 years, with LH increases starting around 35-36 years 6. Therefore, at age 22, she should have the lowest baseline gonadotropin levels of her reproductive life.

Common Pitfalls to Avoid

  1. Timing of measurement: Drawing levels randomly without knowing cycle day makes interpretation nearly impossible. Always obtain samples during days 1-4 of the menstrual cycle for baseline assessment 4, 3

  2. Single measurements: One measurement may not reflect the true hormonal status, as levels fluctuate throughout the cycle 2

  3. Assay variability: Different laboratories use different assays with varying reference ranges—always use local laboratory reference values 4

  4. Interpreting elevated levels: High FSH and LH with high estradiol (>150 pg/mL) may simply represent the mid-cycle surge, not pathology 4

Related Questions

When should luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) be measured?
What is the interpretation of luteinizing hormone (LH) 18 IU/L and follicle‑stimulating hormone (FSH) 14 IU/L in a reproductive‑age female?
For a female patient undergoing infertility evaluation, can the hormone panel (prolactin, testosterone, estradiol, luteinizing hormone, follicle‑stimulating hormone, and anti‑Müllerian hormone) that was ordered to be drawn on day 3 of her menstrual cycle be drawn on day 11 instead?
What does a luteinizing hormone level of 42.8 IU/L, follicle‑stimulating hormone level of 57.7 IU/L, and estradiol level of 22 pg/mL indicate in a 61‑year‑old woman, and what management is recommended?
Does breastfeeding reduce luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) levels?
In a patient with chronic kidney disease and a hemoglobin of 8.5 g/dL, should I start epoetin‑beta therapy and what dosing regimen is recommended?
How long does it take to achieve symptom control after increasing Latuda (lurasidone) from 20 mg to 40 mg?
Should I start trimethoprim‑sulfamethoxazole (Bactrim) for a patient who still has urinary tract infection symptoms after a three‑day course of nitrofurantoin (Macrobid)?
After completing a 5‑day course of nitrofurantoin (Macrobid) and still having urinary tract infection symptoms, should I start trimethoprim‑sulfamethoxazole (Bactrim)?
What is Viibryd (vilazodone) and what are its indications?
What do case studies reveal about the effects of flaxseed on cancer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.